CLBT

CLBT

USD

Cellebrite DI Ltd. Ordinary Shares

$16.240-0.010 (-0.062%)

Precio en Tiempo Real

Tecnología
Software - Infrastructure
Israel

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$16.250

Máximo

$16.305

Mínimo

$15.895

Volumen

1.34M

Fundamentos de la Empresa

Capitalización de Mercado

3.9B

Industria

Software - Infrastructure

País

Israel

Estadísticas de Negociación

Volumen Promedio

1.24M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $11.47Actual $16.240Máximo $26.3

Informe de Análisis de IA

Última actualización: 23 may 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

CLBT (Cellebrite DI Ltd. Ordinary Shares): Analyzing Recent Moves & What Might Come Next

Stock Symbol: CLBT Generate Date: 2025-05-23 02:01:22

Let's break down what's been happening with Cellebrite's stock lately and what the signals might be suggesting. Think of this as looking under the hood to see what's driving things.

Recent News Buzz: What's the Vibe?

Looking at the latest headlines, the feeling around Cellebrite is a bit mixed, but leans positive in terms of company activity and sentiment.

  • First off, the company is getting out there, announcing they'll be at upcoming investor conferences. That's pretty standard stuff, showing they're engaging with the financial community. It's generally seen as a neutral to slightly positive sign.
  • Then there's news about a new product release – their "Spring 2025 Release." Companies putting out new stuff is usually good news, especially for a tech firm like Cellebrite which is all about digital investigation solutions. It suggests innovation and trying to stay ahead.
  • However, we also saw an analyst from Needham maintain their "Buy" rating on the stock, which sounds great, but they actually lowered their price target from $28 down to $24. So, while they still think it's a stock to buy, they see less potential upside than before. That's a bit of a dampener.

Putting it together, the news shows the company is active and innovating, which is positive. An analyst still likes the stock enough to recommend buying, but the lowered target is a yellow flag. Interestingly, the AI analysis of recent news sentiment comes back as "highly positive," suggesting the overall feeling from the news flow is upbeat despite that lowered price target.

Price Check: What's the Stock Been Doing?

Now, let's look at the stock price itself over the last few months.

Back in late February and March, the stock was mostly trading in the $18-$19 range, sometimes pushing above $20 in late March and early April. It had a decent run there for a bit.

But then, around the middle of May (right when that analyst note came out, actually), the price took a pretty sharp dive. It dropped from around $20 down into the $17 range quite quickly. Since that drop, it's been trading mostly sideways, bouncing between roughly $16.70 and $17.50. The last recorded price was around $16.71.

So, the recent trend is clearly down from its April highs, followed by a period of trying to find its footing at a lower level.

Now, here's where it gets interesting: the AI prediction for the next few days is quite bullish. It forecasts price increases of around 1.45% today, 2.86% tomorrow, and 3.96% the day after. This suggests the AI sees potential for a bounce or a short-term upward move from these current lower prices.

Outlook & Ideas: Putting It All Together

Okay, so we have a mix of signals: positive company news (product, investor engagement), mixed analyst view (Buy but lower target), a recent sharp price drop, and a bullish short-term AI prediction.

Based on this specific data, the apparent near-term leaning seems to be cautiously positive, primarily driven by the strong AI prediction for the next few days and the positive news sentiment score, despite the recent price weakness and the analyst's lowered target. The AI seems to think the recent dip might be a temporary thing and sees room for a bounce.

  • Potential Entry Consideration: If you were looking at this stock and found the AI's bullish short-term outlook compelling, the current price area (around $16.70) or slightly higher (like the $17.11-$17.20 range mentioned in the recommendation data) could be considered as potential entry points. Why? Because it's right where the stock has been trading recently after the dip, and the AI predicts it will go up from here. The recommendation data also points to $17.08 as a potential support level, which is right in this neighborhood.
  • Potential Exit/Stop-Loss Consideration: Managing risk is always key.
    • For taking profits, the recommendation data suggests a very near-term target of $17.38. This is close to the recent trading range high and could be a target for a quick bounce trade. Looking further out, the analyst's lowered target is $24, and the AI's projected target is $24.54. These are much higher and would require a significant, sustained upward move, but they give an idea of potential upside if the trend really reverses.
    • For cutting losses (a stop-loss), the recommendation data suggests $15.33. This level is below the recent lows seen during the May 14th drop. If the stock falls below this point, it might signal that the recent weakness is continuing, and the bullish AI prediction isn't playing out.

Company Context

Just a quick reminder about Cellebrite: they are a tech company focused on digital investigation tools. They help law enforcement and companies access and analyze digital data for legal cases. This means their business can be influenced by government spending, cybersecurity trends, and the need for digital evidence in investigations. The new product release fits right into this core business.

Remember, this analysis is based only on the provided data points – the news, the recent price history, and the AI predictions/recommendations.


Disclaimer: This report is for informational purposes only and is based on the provided data. It is not financial advice. Stock investing involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

Analyst Upgrades

Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target

Needham analyst Mike Cikos reiterates Cellebrite DI with a Buy and maintains $24 price target.

Ver más
Needham Reiterates Buy on Cellebrite DI, Maintains $24 Price Target
GlobeNewswire

Cellebrite to Acquire Corellium

TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its

Ver más
Cellebrite to Acquire Corellium
GlobeNewswire

Cellebrite Announces Participation in Upcoming Investor Conferences

TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that

Ver más
Cellebrite Announces Participation in Upcoming Investor Conferences

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 13 jun 2025, 01:38

BajistaNeutralAlcista

69.6% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Crecimiento
Guía de Negociación

Punto de Entrada

$16.22

Toma de Ganancias

$16.56

Stop Loss

$14.62

Factores Clave

PDI 6.7 está por encima de MDI 4.7 con ADX 25.5, lo que sugiere una tendencia alcista
El precio actual está extremadamente cerca del nivel de soporte ($16.18), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 8.5 veces el promedio (15,355), lo que indica una presión de compra extremadamente fuerte
El MACD 0.0342 está por debajo de la línea de señal 0.0349, lo que indica un cruce bajista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.